共 50 条
- [23] The Case for Neoadjuvant Chemotherapy and Cystectomy for Muscle Invasive Bladder Cancer JOURNAL OF UROLOGY, 2009, 181 (05): : 1994 - 1995
- [24] CHANGES IN LEAN MUSCLE MASS ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2017, 197 (04): : E1195 - E1196
- [25] THE IMPACT OF SARCOPENIA AND OBESITY ON THE TOLERABILITY OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2021, 206 : E768 - E768
- [26] Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer JOURNAL OF UROLOGY, 2022, 207 (01): : 70 - 76
- [27] PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN A MULTICENTRE COHORT OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2014, 191 (04): : E558 - E558
- [28] Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy Journal of Experimental & Clinical Cancer Research, 35
- [29] COST EFFECTIVENESS ANALYSIS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2013, 189 (04): : E170 - E170